184
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Technical Evaluation of Soft Mist Inhaler Use in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

, , , , ORCID Icon, & show all
Pages 1471-1479 | Published online: 22 Jun 2020

References

  • LiangCY, ChenYJ, SheuSM, TsaiCF, ChenW. Misuse of inhalers among COPD patients in a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis. 2018;13:1309–1316. doi:10.2147/COPD.S15886429719386
  • WangC, XuJY, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health CPH study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-929650248
  • ZhouMG, WangHD, ZhuJ, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251–272. doi:10.1016/S0140-6736(15)00551-626510778
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 Report). Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed 528, 2020.
  • BystrakT, EisenhowerC. Chronic obstructive pulmonary disease in older adults part ii: considerations for inhaler selection. J Gerontol Nurs. 2018;44(10):10–15. doi:10.3928/00989134-20180913-03
  • PadmanabhanM, TamilarasuK, RajaramM, BatmanabaneG. Inadequate inhaler technique, an everlasting problem associated with poor disease control - a cross-sectional study. Adv Respir Dis. 2019;87(4):217–225. doi:10.5603/ARM.a2019.0021
  • LeeH, BooS, LimY, KimS, KimIA. Accuracy of inhaler use in patients with chronic obstructive pulmonary disease. Clin Nurs Res. 2014;23(5):560–574. doi:10.1177/105477381349826923922162
  • CapstickTGD, CliftonIJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6(1):91–103. doi:10.1586/ers.11.8922283582
  • VirchowJC, CromptonGK, Dal NegroR, et al. Importance of inhaler devices in the management of airway disease. Respir Med. 2008;102(1):10–19. doi:10.1016/j.rmed.2007.07.03117923402
  • LavoriniF. The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy. 2013;2013:1–17. doi:10.1155/2013/102418
  • IbrahimM, VermaR, Garcia-ContrerasL. Inhalation drug delivery devices: technology update. Med Devices. 2015;8:131–139.
  • de OliveiraMVC, PizzichiniE, da CostaCH, et al. Evaluation of the preference, satisfaction and correct use of Breezhaler® and Respimat® inhalers in patients with chronic obstructive pulmonary disease - INHALATOR study. Respir Med. 2018;144:61–67. doi:10.1016/j.rmed.2018.10.00630366585
  • SloweyA, SteinS. 60 years of the MDI - a history of innovation. J Aerosol Med Pulm Drug Deliv. 2017;30(4):A11–A12.
  • Al-ShowairRAM, TarsinWY, AssiKH, PearsonSB, ChrystynH. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101(11):2395–2401. doi:10.1016/j.rmed.2007.06.00817629471
  • RauJL. Practical problems with aerosol therapy in COPD. Respir Care. 2006;51(2):158–172.16441960
  • Van Der PalenJ. Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL®). Respir Med. 2003;97(3):285–289. doi:10.1053/rmed.2003.128912645837
  • ChrystynH. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates. Respir Med. 2003;97(2):181–187. doi:10.1053/rmed.2003.135112587970
  • NsourWM, AlldredA, CorradoOJ, ChrystynH. Measurement of peak inhalation rates with an In-Check Meter® to identify an elderly patient’s ability to use a Turbuhaler®. Respir Med. 2001;95(12):965–968. doi:10.1053/rmed.2001.119011778793
  • IwanagaT, TohdaY, NakamuraS, SugaY. The Respimat® Soft Mist Inhaler: implications of drug delivery characteristics for patients. Clin Drug Investig. 2019;39(11):1021–1030. doi:10.1007/s40261-019-00835-z
  • DalbyR, SpallekM, VoshaarT. A review of the development of Respimat® Soft Mist™ Inhaler. Int J Pharm. 2004;283(1–2):1–9. doi:10.1016/j.ijpharm.2004.06.01815363496
  • FergusonGT, GhafouriM, DaiLY, DunnLJ. COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study. Int J Chron Obstruct Pulmon Dis. 2013;8:139–150. doi:10.2147/COPD.S3857723658479
  • HanadaS, WadaS, OhnoT, SawaguchiH, MurakiM, TohdaY. Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Int J Chron Obstruct Pulmon Dis. 2015;10:69–77. doi:10.2147/COPD.S7352125609941
  • SanchisJ, GichI, PedersenS, et al. Systematic review of errors in inhaler use has patient technique improved over time? Chest. 2016;150(2):394–406. doi:10.1016/j.chest.2016.03.04127060726
  • MelaniAS, BonaviaM, CilentiV, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938. doi:10.1016/j.rmed.2011.01.00521367593
  • LavoriniF, MagnanA, DubusJC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593–604. doi:10.1016/j.rmed.2007.11.00318083019